93 related articles for article (PubMed ID: 6752059)
21. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
23. Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man.
Ratzmann KP; Besch W; Witt S; Schulz B
Horm Metab Res; 1982 Oct; 14(10):508-12. PubMed ID: 6757082
[TBL] [Abstract][Full Text] [Related]
24. [A study on the mechanism of hyperinsulinemia in essential hypertension].
Guan RJ
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):266-8, 314. PubMed ID: 8200304
[TBL] [Abstract][Full Text] [Related]
25. Altered basal C-peptide/insulin molar ratios in obese patients with fatty liver.
Inokuchi T; Watanabe K; Kameyama H; Orita M
Jpn J Med; 1988 Aug; 27(3):272-6. PubMed ID: 3057268
[TBL] [Abstract][Full Text] [Related]
26. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
27. Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
Numata K; Tanaka K; Saito M; Shishido T; Inoue S
Int J Obes Relat Metab Disord; 1993 Feb; 17(2):103-8. PubMed ID: 8384164
[TBL] [Abstract][Full Text] [Related]
28. Disappearance rate of endogenous human C-peptide from blood.
Kuzuya T; Matsuda A
Diabetologia; 1976 Oct; 12(5):519-21. PubMed ID: 976639
[TBL] [Abstract][Full Text] [Related]
29. [Simultaneous determination of blood insulin and plasma C-peptide levels. Value during assessment of glucose tolerance, especially in obese subjects (author's transl)].
Pinget M; Demangeat C; Comte F; Brogard JM; Jacques C; Sapin R; Dorner M
Ann Endocrinol (Paris); 1980; 41(5):399-414. PubMed ID: 7015991
[TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance.
De Marinis L; Mancini A; Zuppi P; Sammartano L; Valle D; Fiumara C; Sandric S; Folli G
Diabetes Res; 1992 Jan; 19(1):9-16. PubMed ID: 1468187
[TBL] [Abstract][Full Text] [Related]
31. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
[TBL] [Abstract][Full Text] [Related]
32. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels.
Rossell R; Gomis R; Casamitjana R; Segura R; Vilardell E; Rivera F
J Clin Endocrinol Metab; 1983 Mar; 56(3):608-11. PubMed ID: 6337182
[TBL] [Abstract][Full Text] [Related]
33. C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity.
Savage PJ; Flock EV; Mako ME; Blix PM; Rubenstein AH; Bennett PH
J Clin Endocrinol Metab; 1979 Apr; 48(4):594-8. PubMed ID: 429504
[TBL] [Abstract][Full Text] [Related]
34. Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.
Giugliano D; Cozzolino D; Torella R; Lefebvre PJ; Franchimont P; D'Onofrio F
Acta Endocrinol (Copenh); 1991 Feb; 124(2):159-65. PubMed ID: 2003375
[TBL] [Abstract][Full Text] [Related]
35. Insulin and C-peptide secretory responses to glucagon in man: studies on the dose-response relationships.
Ahrén B; Nobin A; Scherstén B
Acta Med Scand; 1987; 221(2):185-90. PubMed ID: 3296670
[TBL] [Abstract][Full Text] [Related]
36. An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice.
Karakash C; Assimacopoulos-Jeannet F; Jeanrenaud B
J Clin Invest; 1976 May; 57(5):1117-24. PubMed ID: 1262459
[TBL] [Abstract][Full Text] [Related]
37. Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.
Scott RS; Espiner EA; Donald RA; Ellis MJ
Aust N Z J Med; 1980 Apr; 10(2):146-50. PubMed ID: 6992759
[TBL] [Abstract][Full Text] [Related]
38. [Immunoreactive insulin and C-peptide in glucose tolerance disturbances in the relatives of diabetes mellitus patients].
Mazovetskiĭ AG; Zavadskiĭ PS; Tursunov B; Masenko VP
Probl Endokrinol (Mosk); 1980; 26(1):8-12. PubMed ID: 7360741
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
Kåresen R; Tronier B; Aune S
Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
[TBL] [Abstract][Full Text] [Related]
40. Responses of plasma insulin C-peptide and proinsulin-like components to glucose and glucagon in the pig.
Kobayashi K
Endocrinol Jpn; 1975 Dec; 22(6):489-96. PubMed ID: 1231990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
